NCT02188563

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Efficacy and Impact of a Comprehensive Smoking Cessation Intervention During Radiation for Upper Aerodigestive Cancers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
• Sex: All
• Age: 18 Years – 105 Years
• Healthy volunteers: Not accepted

Summary

Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.

Conditions

• Tobacco Use Disorder
• Head and Neck Neoplasms
• Thoracic Neoplasms
• Radiation

Interventions

Type	Name	Description
OTHER	Comprehensive smoking cessation intervention
BEHAVIORAL	Enhanced usual care

Timeline

• Start date: 2014-05-01
• Primary completion: 2015-05-01
• Completion: 2016-05-01
• First posted: 2014-07-11
• Last updated: 2019-01-17

Locations

1 site across 1 country: United States